Publications

May 16, 2023

Gene Editing and Immunotherapeutic Targeting of ADGRE2/EMR2 to Enable Combinatorial Targeting in Acute Myeloid Leukemia (AML)

Discovery Platform, Platform

ASGCT – 2023 – Poster Presentation 618